{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:34:04Z","timestamp":1792089244640,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.colsurfb.2021.112304","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T11:20:53Z","timestamp":1640258453000},"page":"112304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Design of transfersomal nanocarriers of nystatin for combating vulvovaginal candidiasis; A different prospective"],"prefix":"10.1016","volume":"211","author":[{"given":"Mayssa Abdel","family":"Hady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa B.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama M.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"Achkar","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","article-title":"Recurrent vulvovaginal candidiasis","volume":"214","author":"Sobel","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"26","key":"10.1016\/j.colsurfb.2021.112304_bib3","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJM199712253372607","article-title":"Vaginitis","volume":"337","author":"Sobel","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0022034511399285","article-title":"Epithelial cell innate response to Candida albicans","volume":"23","author":"Naglik","year":"2011","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.colsurfb.2021.112304_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fmicb.2015.00625","article-title":"Host-pathogen interactions between the human innate immune system and Candida albicans\u2014understanding and modeling defense and evasion strategies","volume":"6","author":"D\u00fchring","year":"2015","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib6","first-page":"67","article-title":"Development of liposomal polyene antibiotics: an historical perspective","volume":"6","author":"Ng","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2021.112304_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12292","article-title":"Guideline: vulvovaginal candidosis (AWMF 015\/072), S2k (excluding chronic mucocutaneous candidosis)","volume":"58","author":"Mendling","year":"2015","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.colsurfb.2021.112304_bib8","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/S0006-3495(03)70032-0","article-title":"Cooperative partition model of nystatin interaction with phospholipid vesicles","volume":"84","author":"Coutinho","year":"2003","journal-title":"Biophys. J."},{"issue":"10","key":"10.1016\/j.colsurfb.2021.112304_bib9","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1529\/biophysj.105.075408","article-title":"Competitive binding of cholesterol and ergosterol to the polyene antibiotic nystatin. A fluorescence study","volume":"90","author":"Silva","year":"2006","journal-title":"Biophys. J."},{"issue":"16","key":"10.1016\/j.colsurfb.2021.112304_bib10","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1021\/bi962894z","article-title":"The formation of amphotericin B ion channels in lipid bilayers","volume":"36","author":"Fujii","year":"1997","journal-title":"Biochemistry"},{"issue":"48","key":"10.1016\/j.colsurfb.2021.112304_bib11","doi-asserted-by":"crossref","first-page":"32304","DOI":"10.1074\/jbc.273.48.32304","article-title":"Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase","volume":"273","author":"Park","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12617","article-title":"Lipid rafts in immune signalling: current progress and future perspective","volume":"149","author":"Varshney","year":"2016","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejps.2013.03.006","article-title":"Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system","volume":"49","author":"P\u00e1l","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2003.11.003","article-title":"The effects of Pluronic block copolymers on the aggregation state of nystatin","volume":"95","author":"Croy","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2021.112304_bib15","series-title":"Drug Information","first-page":"528","article-title":"Nystatin","author":"Evoy","year":"2004"},{"key":"10.1016\/j.colsurfb.2021.112304_bib16","series-title":"The Complete Drug Reference","first-page":"543","article-title":"Nystatin, in Martindale","author":"Sweetman","year":"2009"},{"issue":"11","key":"10.1016\/j.colsurfb.2021.112304_bib17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/17425247.2010.525230","article-title":"Topical delivery of antifungal agents","volume":"7","author":"Kaur","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1439-0507.2012.02202.x","article-title":"Evaluation of novel nystatin nanoemulsion for skin candidosis infections","volume":"56","author":"Fern\u00e1ndez-Campos","year":"2013","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.colsurfb.2021.112304_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00449-012-0797-y","article-title":"Metallic silver nanoparticle: a therapeutic agent in combination with antifungal drug against human fungal pathogen","volume":"36","author":"Singh","year":"2013","journal-title":"Bioprocess Biosyst. Eng."},{"key":"10.1016\/j.colsurfb.2021.112304_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/418316","article-title":"Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes","volume":"2011","author":"Duangjit","year":"2011","journal-title":"J. Drug Deliv."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijpharm.2011.12.019","article-title":"Predicting hydrophilic drug encapsulation inside unilamellar liposomes","volume":"423","author":"Xu","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.colsurfb.2021.112304_bib23","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.75.9.4194","article-title":"Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation","volume":"75","author":"Szoka","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib24","first-page":"252","article-title":"Recent advances in NDDS (Novel Drug Delivery System) for delivery of anti-hypertensive drugs","volume":"3","author":"Vikas","year":"2011","journal-title":"Int J. Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/20022727.2017.1325708","article-title":"Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art","volume":"8","author":"Rai","year":"2017","journal-title":"Nano Rev. Exp."},{"key":"10.1016\/j.colsurfb.2021.112304_bib26","unstructured":"Bhasin B., Londhe V., Nmims S.s., Patel S.P. , An overview of Transfersomal Drug Delivery, 2018."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(94)90228-3","article-title":"Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85)","volume":"105","author":"Yoshioka","year":"1994","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","article-title":"Non-ionic surfactant based vesicles (niosomes) in drug delivery","volume":"172","author":"Uchegbu","year":"1998","journal-title":"Int. J. Pharm."},{"issue":"21","key":"10.1016\/j.colsurfb.2021.112304_bib29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.drudis.2012.06.013","article-title":"Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents","volume":"17","author":"Kumar","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.colsurfb.2021.112304_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","article-title":"Nano-niosomes as nanoscale drug delivery systems: an illustrated review","volume":"185","author":"Moghassemi","year":"2014","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.colsurfb.2021.112304_bib31","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM198612043152305","article-title":"Recurrent vulvovaginal candidiasis","volume":"315","author":"Sobel","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.colsurfb.2021.112304_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.2042-7158.1985.tb04990.x","article-title":"The preparation and properties of niosomes\u2014non-ionic surfactant vesicles","volume":"37","author":"Baillie","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.colsurfb.2021.112304_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.colsurfb.2012.05.010","article-title":"Phospholipid based colloidal poloxamer\u2013nanocubic vesicles for brain targeting via the nasal route","volume":"100","author":"Salama","year":"2012","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/20022727.2017.1325708","article-title":"Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art","volume":"8","author":"Rai","year":"2017","journal-title":"Nano Rev. Exp."},{"issue":"4","key":"10.1016\/j.colsurfb.2021.112304_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10611860600720384","article-title":"Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model","volume":"14","author":"Khan","year":"2006","journal-title":"J. Drug Target."},{"issue":"12","key":"10.1016\/j.colsurfb.2021.112304_bib36","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.31.12.1901","article-title":"Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections","volume":"31","author":"Mehta","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.colsurfb.2021.112304_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/10611860412331285215","article-title":"Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice","volume":"12","author":"Khan","year":"2004","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.colsurfb.2021.112304_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.femsim.2004.03.011","article-title":"Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice","volume":"41","author":"Khan","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/1061186031000119093","article-title":"Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B","volume":"11","author":"Khan*","year":"2003","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dki454","article-title":"Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model","volume":"57","author":"Nasti","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.colsurfb.2021.112304_bib41","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1128\/AAC.42.8.1878","article-title":"Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins","volume":"42","author":"Cassidy","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.colsurfb.2021.112304_bib42","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/AAC.41.9.1871","article-title":"Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma","volume":"41","author":"Wasan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.colsurfb.2021.112304_bib43","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.31.12.1897","article-title":"Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis","volume":"31","author":"Mehta","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.colsurfb.2021.112304_bib44","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3109\/03639045.2011.587431","article-title":"Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin","volume":"37","author":"El-Ridy","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.colsurfb.2021.112304_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/10717541003706257","article-title":"Preparation and characterization of niosomes containing ribavirin for liver targeting","volume":"17","author":"Hashim","year":"2010","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","article-title":"Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes","volume":"361","author":"Mokhtar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2021.112304_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.carbpol.2014.09.032","article-title":"Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery","volume":"117","author":"Mart\u00edn","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2021.112304_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molliq.2016.02.081","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: design, optimization, in vitro and in vivo evaluation","volume":"218","author":"Kassem","year":"2016","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.colsurfb.2021.112304_bib49","first-page":"1855","article-title":"Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer","volume":"9","author":"Matthaiou","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.colsurfb.2021.112304_bib50","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/1567201812666150703115126","article-title":"Benzocaine loaded solid lipid nanoparticles: formulation design, in vitro and in vivo evaluation of local anesthetic effect","volume":"12","author":"Basha","year":"2015","journal-title":"Curr. Drug Deliv."},{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","article-title":"Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation","volume":"30","author":"Khallaf","year":"2020","journal-title":"J. Liposome Res."},{"issue":"3","key":"10.1016\/j.colsurfb.2021.112304_bib52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/02652049709051137","article-title":"In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition","volume":"14","author":"Beaulac","year":"1997","journal-title":"J. Microencapsul."},{"issue":"12","key":"10.1016\/j.colsurfb.2021.112304_bib53","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.3390\/molecules161210269","article-title":"Preparation, spectrochemical, and computational analysis of l-carnosine (2-[(3-aminopropanoyl) amino]-3-(1H-imidazol-5-yl) propanoic acid) and its ruthenium (II) coordination complexes in aqueous solution","volume":"16","author":"Branham","year":"2011","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijpharm.2012.08.015","article-title":"Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis\u2014dermatophytosis","volume":"437","author":"Aggarwal","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2021.112304_bib55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4028\/www.scientific.net\/AMR.194-196.537","article-title":"Effect of edge activator on characteristic and in vitro skin permeation of meloxicam loaded in elastic liposomes","volume":"194\u2013196","author":"Duangjit","year":"2011","journal-title":"Adv. Mater. Res."},{"issue":"3","key":"10.1016\/j.colsurfb.2021.112304_bib56","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12249-008-9105-1","article-title":"Niosome-encapsulated gentamicin for ophthalmic controlled delivery","volume":"9","author":"Abdelbary","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0378-5173(00)00362-8","article-title":"The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether","volume":"201","author":"Arunothayanun","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2021.112304_bib58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.colsurfb.2012.05.010","article-title":"Phospholipid based colloidal poloxamer\u2013nanocubic vesicles for brain targeting via the nasal route","volume":"100","author":"Salama","year":"2012","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.colsurfb.2021.112304_bib59","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jps.21944","article-title":"Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery","volume":"99","author":"Bayindir","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2021.112304_bib60","first-page":"88","article-title":"Co-assembly of chitosan and phospholipids into hybrid hydrogels","author":"Mendes","year":"2016","journal-title":"Pure Appl. Chem."},{"issue":"9","key":"10.1016\/j.colsurfb.2021.112304_bib61","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/pharmaceutics12090855","article-title":"Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery","volume":"12","author":"Opatha","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2021.112304_bib62","unstructured":"Kumar, M.S., Preeti, Development of CelecoxibTransfersomal gel for the Treatment of Rheumatoid Arthritis, 2014."},{"key":"10.1016\/j.colsurfb.2021.112304_bib63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jddst.2017.03.007","article-title":"Development and optimization of ketoconazole loaded nano-transfersomal gel for vaginal delivery using Box-Behnken design: in vitro, ex vivo characterization and antimicrobial evaluation","volume":"39","author":"Singh","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(89)90306-2","article-title":"A simple equation for the description of solute release. III. Coupling of diffusion and relaxation","volume":"57","author":"Peppas","year":"1989","journal-title":"Int J. Pharm."},{"issue":"5","key":"10.1016\/j.colsurfb.2021.112304_bib65","first-page":"421","article-title":"Preparation and characterization of repaglinide loaded ethylcellulose nanoparticles by solvent diffusion technique using high pressure homogenizer","volume":"7","author":"Lokhande","year":"2013","journal-title":"J. Pharm. Res."},{"issue":"2","key":"10.1016\/j.colsurfb.2021.112304_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/08982104.2018.1524482","article-title":"Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization","volume":"29","author":"Khalil","year":"2019","journal-title":"J. Liposome Res."},{"issue":"5","key":"10.1016\/j.colsurfb.2021.112304_bib67","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0006-3495(92)81708-3","article-title":"Phase transition behavior of single phosphatidylcholine bilayers on a solid spherical support studied by DSC NMR and FT-IR","volume":"63","author":"Naumann","year":"1992","journal-title":"Biophys. J."},{"key":"10.1016\/j.colsurfb.2021.112304_bib68","article-title":"Formulation and evaluation of nystatin microparticles as a sustained release system","volume":"2015","author":"Ismail","year":"2019","journal-title":"Iraqi J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2021.112304_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/pharmaceutics10040185","article-title":"Brief effect of a small hydrophobic drug (cinnarizine) on the physicochemical characterisation of niosomes produced by thin-film hydration and microfluidic methods","volume":"10","author":"Yeo","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.colsurfb.2021.112304_bib70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ddr.21632","article-title":"Investigation of a new horizon antifungal activity with enhancing the antimicrobial efficacy of ciprofloxacin and its binary mixture via their encapsulation in nanoassemblies: in vitro and in vivo evaluation","volume":"81","author":"Abou Taleb","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.colsurfb.2021.112304_bib71","first-page":"21","article-title":"Preparation and characterization of rutin-loaded nanophytosomes","author":"Ghanbarzadeh","year":"2015","journal-title":"Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2021.112304_bib72","series-title":"Analytical Profiles of Drug Substances","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0099-5428(08)60349-4","article-title":"Nystatin","author":"Michel","year":"1977"},{"key":"10.1016\/j.colsurfb.2021.112304_bib73","first-page":"560","article-title":"Transfersomes as a transdermal drug delivery system for enhancement the antifungal activity of nystatin","volume":"5","author":"Abdallah","year":"2013","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.05.029","article-title":"Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: in-vitro, ex-vivo and in-vivo evaluation","volume":"527","author":"Abdellatif","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2021.112304_bib75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/pharmaceutics10010026","article-title":"Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections","volume":"10","author":"Qushawy","year":"2018","journal-title":"Pharmaceutics"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776521007505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776521007505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:07:04Z","timestamp":1760526424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776521007505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":75,"alternative-id":["S0927776521007505"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112304","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of transfersomal nanocarriers of nystatin for combating vulvovaginal candidiasis; A different prospective","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112304"}}